AzTrials
AzTrials

Chronic Low-back PainDN-PE-LBPNCT06505161

Dry Needling Versus Percutaneous Electrolysis in Lumbar Multifidus Muscles in Patients With Chronic Low Back Pain.

A study testing Dry needling and Percutaneous electrolysis in people with Chronic Low-back Pain, run by University of Alcala at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the reduction of pain of two different treatments in patients with chronic low back pain. Patients were divided in two groups. The control group will receive DN treatment, and the experimental group will receive PE, both in the lumbar multifidus muscles. Read more about this study

Who is it for?
Ages 30 to 60 years
Conditions the study is for
Chronic Low-back Pain
What is being tested?
Dry needling and Percutaneous electrolysis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSpain
Study dates
1 Sep 2024to 1 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Low back pain ≥ 3 months.
  • Age between 30 and 60 years old.
  • Not being receiving other physical therapy

Who cannot join

  • Diagnosis of specific lumbar pathology.
  • History of previous lumbar surgery.
  • Treatment with corticosteroids, anti-inflammatory or antibiotic medication in recent weeks.
  • Oncological processes, febrile symptoms or thrombophlebitis.
  • Skin conditions.
  • Belonephobia.
Show all 9Show fewer
  • Pacemaker.
  • Pregnancy.
  • Patients with neurological pathology

Trial locations and contacts

1 site in 1 country.

Leire Lopez de Calle Sánchez, Grade contact

+34661620517

leire.lopezc@edu.uah.es

Samuel Fernandez Carnero, PhD contact

samuel.fernandezc@uah.es

Spain1 site
  • Campus Científico-Tecnológico UAH. Av. de León, 3A

    Alcalá de Henares, Madrid, 28805

    Leire López de Calle Sánchez, Grade, +34661620517, leire.lopezc@edu.uah.es

Other trials in Spain

About this study

Official title: Dry Needling Versus Percutaneous Electrolysis in Lumbar Multifidus Muscles in Patients With Chronic Low Back Pain

The aim of this study is to evaluate the reduction of pain of two different treatments in patients with chronic low back pain. Patients were divided in two groups. The control group will receive DN treatment, and the experimental group will receive PE, both in the lumbar multifidus muscles.

Read the detailed description

Background: Low back pain is one of the most common health problems and a leading cause of disability and absence from work. Between 70% and 80% of adults will experience an episode of low back pain and approximately 10.0% of them will become chronic. This has a direct impact on the lumbar stabilizing muscles, giving rise to both structural and functional changes. Among the different treatment options, it has been observed that both dry needling (DN) and percutaneous electrolysis (PE) are effective techniques in the management of musculoskeletal pain.

Aim: To evaluate whether the reduction of pain after the application of PE is superior to the one obtained with DN.

Methods: A single-blind randomized clinical trial will be conducted in patients with chronic low back pain. The subjects will be divided into two groups. The control group will receive DN treatment, and the experimental group will receive PE, both in the lumbar multifidus muscles. The study variables will be: pain (VAS), disability index (Oswestry Scale), fear of movement (TSK-11SV) and quality of life (SF-12). The measurements will be assessed before, right after and 7 days after a single intervention.

Being tested
Dry needling, Percutaneous electrolysis
Keywords
chronic low back pain, Dry needling, Percutaneous electrolysis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dry needlingOther

    It consists in application of dry needling on active and/or latent TPs in low back multifidus muscles

  • Percutaneous electrolysisOther

    It consists in the application of intratissue percutaneous electrolysis with galvanic current as a cathodic flow electrode in the low back multifidus muscles. The intervention will be guided by ultrasound equipment medically certified.

Study groups in NCT06505161
Study groupRoleWhat they receive
Dry needling groupActive comparatorThe dry needling group will recibe a dry needling treatment with the Hong technique.
Receives: Other: Dry needling
Percutaneous electrolysis groupExperimentalThe percutaneous electrolysis grupos will recibe a tratement of galvanic current at 1.5mA, with 3-5 impacts, for 3-5 seconds in the low back multifiud muscles.
Receives: Other: Percutaneous electrolysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity. Visual analogue scale.

    A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain

    Measured: At baseline, at 1 week after the last intervention, and 6-month follow-up period

Secondary outcomes (3)
  1. Disability. Oswestry Low Back Pain Disability Idex

    It has 10 items associated to activities of daily living, each item has a punctuation from 0 to 5 points

    Measured: At baseline, at 1 week after the last intervention, and 6-month follow-up period

  2. Fear of Movement. Tampa Scale of kinesiophobia (TSK-11SV)

    Is a 11-item questionnaire that measures the fear of movement and (re)injury.

    Measured: At baseline, at 1 week after the last intervention, and 6-month follow-up period

  3. Quality of life. SF-12 Health questionnaire.

    SF-12 Health questionnaire scores range from 0 to 100% and indicate the self-perceived health-related quality of life

    Measured: At baseline, at 1 week after the last intervention, and 6-month follow-up period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2024
  2. Study start1 Sep 2024 (estimated)
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The subjects will be divided into two groups. The control group will receive DN treatment, and the experimental group will receive PE, both in the lumbar multifidus muscles.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06505161
Sponsor's protocol ID
Dry needling Electrolysis
Acronym
DN-PE-LBP
Status last verified
Jul 2024
First submitted
10 Jul 2024
Last updated
17 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ng SK, Urquhart DM, Fitzgerald PB, Cicuttini FM, Hussain SM, Fitzgibbon BM. The Relationship Between Structural and Functional Brain Changes and Altered Emotion and Cognition in Chronic Low Back Pain Brain Changes: A Systematic Review of MRI and fMRI Studies. Clin J Pain. 2018 Mar;34(3):237-261. doi: 10.1097/AJP.0000000000000534.

    PubMed 28719509
  • Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007 Oct 2;147(7):478-91. doi: 10.7326/0003-4819-147-7-200710020-00006.

    PubMed 17909209
  • Matheve T, Hodges P, Danneels L. The Role of Back Muscle Dysfunctions in Chronic Low Back Pain: State-of-the-Art and Clinical Implications. J Clin Med. 2023 Aug 24;12(17):5510. doi: 10.3390/jcm12175510.

    PubMed 37685576
  • Hodges PW, Danneels L. Changes in Structure and Function of the Back Muscles in Low Back Pain: Different Time Points, Observations, and Mechanisms. J Orthop Sports Phys Ther. 2019 Jun;49(6):464-476. doi: 10.2519/jospt.2019.8827.

    PubMed 31151377
  • Hu HT, Gao H, Ma RJ, Zhao XF, Tian HF, Li L. Is dry needling effective for low back pain?: A systematic review and PRISMA-compliant meta-analysis. Medicine (Baltimore). 2018 Jun;97(26):e11225. doi: 10.1097/MD.0000000000011225.

    PubMed 29952980
  • Fakontis C, Iakovidis P, Lytras D, Kasimis K, Koutras G, Ntinou SR, Kottaras A, Chatziprodromidou IP, Chatzikonstantinou P, Apostolou T. Efficacy of percutaneous needle electrolysis versus dry needling in musculoskeletal pain: A systematic review and meta-analysis. J Back Musculoskelet Rehabil. 2023;36(5):1033-1046. doi: 10.3233/BMR-220408.

    PubMed 37458028
  • Valera-Calero JA, Sanchez-Mayoral-Martin A, Varol U. Short-term effectiveness of high- and low-intensity percutaneous electrolysis in patients with patellofemoral pain syndrome: A pilot study. World J Orthop. 2021 Oct 18;12(10):781-790. doi: 10.5312/wjo.v12.i10.781. eCollection 2021 Oct 18.

    PubMed 34754834

Questions about this trial

What is this clinical trial studying?

A study testing Dry needling and Percutaneous electrolysis in people with Chronic Low-back Pain, run by University of Alcala at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Leire Lopez de Calle Sánchez, Grade (+34661620517, leire.lopezc@edu.uah.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity. Visual analogue scale. (time frame: At baseline, at 1 week after the last intervention, and 6-month follow-up period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06505161, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in